You're reading the free version. Trader adds the live tape and alerts.
Start tracking
HALO Award Disclosure
Snellgrove Darren · SEC Form 4 · Filed Jul 2, 2026
Award
Calculated transaction value
$0
Snellgrove Darren SVP, Chief Financial Officer
HALO
Transaction date
Jul 1, 2026
Public filing date
Jul 2, 2026
Filing lag
Filed 1 day later
HALO daily price context
Close on/before transaction
$77.01
Jul 1, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Restricted Stock Units on Common Stock
- Quantity / price
- 41,554 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001159036-26-000095
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Halozyme Therapeutics, Inc. HALO Current | Award | Jul 1, 2026 | $0 |
| Halozyme Therapeutics, Inc. HALO | Award | Jul 1, 2026 | $0 |